Search all trials

Find therapies in clinical trials near you – page 14

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Psoriasis

Not yet recruiting

Registered drug

Study on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Deucravacitinib

Contact Research Centre

Dermatitis atopic

Not yet recruiting

Registered drug

Study of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Ly3454738

Contact Research Centre

Atrial fibrillation

Not yet recruiting

Investigational

Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Regn7508

Contact Research Centre

Type 2 diabetes mellitus

Not yet recruiting

Registered drugNo placebo

Phase 3 Study of Oral Orforglipron vs Weekly Dulaglutide in Children and Adolescents (10‑<18 years) with Type 2 Diabetes

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Dulaglutide

Contact Research Centre

Heart failure with reduced ejection fraction

Not yet recruiting

Investigational

A study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction

Investigational

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Dermatitis atopic

Not yet recruiting

Investigational

Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Adults with Moderate to Severe Atopic Dermatitis (Phase 2 Study)

Investigational

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Chronic graft versus host disease

Not yet recruiting

Registered drugNo placebo

Study of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

VEXAS syndrome

Not yet recruiting

Investigational

Randomized Study of SIR9900 for Safety and Effectiveness in Patients with VEXAS Syndrome

Investigational

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Adrenogenital syndrome

Not yet recruiting

InvestigationalNo placebo

Study of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Androgen Levels

InvestigationalNo placebo

Italy

Participants:18–64 years
Substances:Crinecerfont

Contact Research Centre

Cardiac amyloidosis

Not yet recruiting

Registered drug

Efficacy and safety of eplontersen sodium plus ALXN2220 in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM)

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Alxn2220

Contact Research Centre

Systemic scleroderma

Not yet recruiting

Registered drug

Safety and Efficacy of MTX-474 in Adults with Diffuse Cutaneous Systemic Sclerosis (dcSSc) – A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Glucose Monohydrate

Contact Research Centre

Hepatocellular carcinoma

Not yet recruiting

Registered drugNo placebo

Phase 2 Study of Durvalumab + Tremelimumab with Lenvatinib vs Durvalumab + Tremelimumab Alone in Patients with Unresectable Hepatocellular Carcinoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Find therapies in clinical trials near you – page 14

370 trials match your criteria

Psoriasis

Study on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis

Dermatitis atopic

Study of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults

Atrial fibrillation

Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)

Type 2 diabetes mellitus

Phase 3 Study of Oral Orforglipron vs Weekly Dulaglutide in Children and Adolescents (10‑<18 years) with Type 2 Diabetes

Heart failure with reduced ejection fraction

A study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction

Dermatitis atopic

Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Adults with Moderate to Severe Atopic Dermatitis (Phase 2 Study)

Chronic graft versus host disease

Study of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy

VEXAS syndrome

Randomized Study of SIR9900 for Safety and Effectiveness in Patients with VEXAS Syndrome

Adrenogenital syndrome

Study of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Androgen Levels

Cardiac amyloidosis

Efficacy and safety of eplontersen sodium plus ALXN2220 in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM)

Systemic scleroderma

Safety and Efficacy of MTX-474 in Adults with Diffuse Cutaneous Systemic Sclerosis (dcSSc) – A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

Hepatocellular carcinoma

Phase 2 Study of Durvalumab + Tremelimumab with Lenvatinib vs Durvalumab + Tremelimumab Alone in Patients with Unresectable Hepatocellular Carcinoma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.